throbber
MOLECULAR BIOLOGY OF
`
`THE CELL
`
`Bruce Alberts • Dennis Bray
`Julian Lewis • Martin Raff • Keith Roberts
`James D. Watson
`
`Garland Publishing, Inc.
`New York & London
`
`Genzyme Ex. 1010, pg 258
`
`

`
`"Long ago it became evident that the key to every biological problem must
`finally be sought in the cell, for every living organism is, or at sometime has
`been, a cell."
`
`Edmund B. Wilson
`The Cell in Development and Heredity
`3rd edition, 1925, Macmillan, Inc.
`
`Bruce Alberts received his Ph.D. from Hatvard University and is
`·ut•t•e mlv n PrOf(:ssut·lll tho Depil t·tment o f Hio hcmislly and
`lliophy~ics a l lh tl n lve t-s.ity o f CaUfol'nia Medl a! Schoo l it1 San
`l'l'i.tn c:isco. Ocunis /k;~y t'eCftivcd his Ph .D. !'tum th u Massachusetts
`Institute of Technology and is currently a Senior Scientist in the
`Medical Research Council Cell Biophysics Unit at King's College
`London. Julian Lewis received his D.Phil. from Oxford University and
`is currently a Lecturer in the Anatomy Department at King's College
`London. Martin Raff received his M.D. degree from McGill University
`and is currently a Professor in the Zoology Department at University
`College London. Keith Roberts received his Ph.D. from Cambridge
`University and is currently Head of the Department of Cell Biology at
`the John Innes Institute, Nmwich. James D. Watson received his
`Ph.D. from the University of Indiana and is currently Director of the
`Cold Spring Harbor Laboratmy. He is the author of Molecular Biology
`of the Gene and, with Francis Crick and Maurice Wilkins, won the
`Nobel Prize in Medicine and Physiology in 1962.
`
`© 1983 by Bruce Alberts, Dennis Bray, Julian Lewis, Martin Raff,
`Keith Roberts, and James D. Watson.
`
`All rights rese1ved. No part of this book covered by the copyright
`hereon may be reproduced or used in any fonn m· by any means(cid:173)
`graphic, electronic, or mechanical, including photocopying,
`mcording, taping, or information storage and retrieval systems(cid:173)
`without permission of the publisher.
`
`Library of Congress Cataloging in Publication Data
`Main entry under title:
`
`Molecular biology of the cell.
`
`Includes bibliographies and index.
`1. Cytology. 2. Molecular biology. I. Alberts,
`Bruce, 1938-
`[DNLM: 1. Cells. 2. Molecular
`biology. QH 581.2 M718]
`QH581.2.M64 1983
`ISBN 0-8240-7282-0
`
`82-15692
`
`574.87
`
`Published by Garland Publishing, Inc.
`136 Madison Avenue, New York, NY 10016
`
`Printed in the United States of America
`
`15 14 13 12 11 10 9 8 7 6 5 4 3
`
`Genzyme Ex. 1010, pg 259
`
`

`
`I
`
`& c:
`0
`~
`!':
`QJ c:
`E
`.~
`
`:;)
`
`0
`
`i
`
`injection of tolerouen ic
`form of antigen A
`
`no
`response to
`antigen A
`
`10
`
`20
`
`The Functional Properties of Antibodies 963
`
`Figure 17-14 The experimental
`induction of immunological tolerance
`to a foreign antigen. The injection of
`a tolerance-inducing (tolerogenic)
`dose and/or form of antigen A (see
`text) not only fails to induce an
`immune response but also renders
`the animal specifically unresponsive
`to further injections of antigen A
`given in a form and dose that would
`normally induce a response. Note
`that the response to a different
`antigen, B,.is unaffected.
`
`pri mary response
`to antigen B
`
`60
`
`i
`
`70
`
`80
`
`90
`
`time (days) ___....,.
`
`injection of immunogeni c
`form of antigens A and B
`
`spond to a particular antigen are eliminatedi in other cases they survive, but
`their responses are specifically suppressed by a subclass of T cells known as
`suppressor T cells (seep. 997).
`In summary, the binding of an antigen to its complementary receptors
`on aT orB lymphocyte can have any one of at least three consequences: (1)
`the lymphocyte may divide and differentiate to become an effector cell or a
`memory celli (2) it may become toleranti or (3) it may be unaffected by the
`encounter. The "decision" to turn on, turn off, or ignore depends largely on
`the nature and concentration of the antigen and upon complex interactions
`between different classes of lymphocytes and between lymphocytes and spe(cid:173)
`cialized macrophagelike antigen-presenting cells, which will be discussed in
`a later section. The decision also depends on the maturity of the lymphocyte.
`For example, newly formed B cells are highly susceptible to the induction of
`tolerance, while mature B cells are relatively resistantj this means that devel(cid:173)
`oping B cells with a high affinity for self molecules in their environment will
`become tolerant and never be activated.
`
`Summary
`The immune system evolved to defend vertebrates against infection. It is com(cid:173)
`posed of billions of lymphocytes comprising millions of different clones. The
`lymphocytes in each clone share a unique cell-surface receptor that enables
`them to bind a particular "antigenic determinant" consisting of an arrangement
`of atoms on a part of a molecule. There are two classes of lymphocytes: B cells,
`which make antibodies, and T cells, which make cell-mediated immune re(cid:173)
`sponses.
`Beginning early in lymphocyte development, those B and T cells with re(cid:173)
`ceptors for antigenic determinants on self molecules are eliminated or sup(cid:173)
`pressedj as a result, the immune system is normally able to respond only to
`foreign antigens. The binding of a foreign antigen to a lymphocyte initiates a
`response by the cell that helps to eliminate the antigen. As part of the response,
`some of the lymphocytes proliferate and differentiate into memory cells, so
`that the ne((t time that the same antigen is encountered the immune response
`is faster and much greater.
`
`The Functional Properties o:f Antibodies 11
`The only known function of B lymphocytes is to make antibodies. A unique
`feature of antibodies, one that distinguishes them from all other known pro(cid:173)
`teins, is that they can exist in millions of different forms, each with its own
`unique binding site for antigen. Collectively called immunoglobulins (abbre(cid:173)
`viated as Ig), they represent one of the major classes of proteins found in the
`blood, constituting about 20% of the total plasma protein by weight.
`
`Genzyme Ex. 1010, pg 260
`
`

`
`
`
`HG4 The Immune System
`
`The Antigen-specific Receptors on B Cells
`Are Antibody Molecules 12
`
`As predicted by the clonal selection hypothesis, all of the antibody molecules
`made by an individual B cell have the same antigen-binding site. The first
`antibodies made by a newly fo ,·med B ceil are not secretedi instead they ar
`inserted into the plasma membrane, where they se1ve as receprm·s for antigen .
`Each n cell bas approximately 105 swih antibody molecules in its plasma
`membrane.
`When antigen binds to the antibody molecules on the sul'face of a resting
`B cell, it u ually initiates a complicated and pood understood sedes of ev nts
`culminating in cell proliferation and differentiation to produce antibody-se(cid:173)
`creting c lis. Such cells now make large amounts of soluble (J'alh r than mem(cid:173)
`brane-bound) antibody with the same antigen-binding site as the cell-surface
`antibody and secrete it into the blood. While activated B cells can begin se(cid:173)
`creting antibod whil ~ the 1 are still small lymphocytes, the end stage of this
`differentiation pathway is the la1·ge plasma c U (see Figure 17-4B), which se(cid:173)
`cretes antibodies at the rate of about 2000 molecules per second. Plasma cells
`seem to have committed so much of their protein-synthesizing machinery to
`making antibody U1at t'J1e are incapable of further gmwth and division and
`die after several days of antibody secretion.
`
`B Cells Can Be Stimulated to Make Antibodies
`in a Culture Dish 13
`
`Two significant advances in the 1960s revolutionized research on B cells. The
`first was the development of the hemolytic plaque assay, which made it
`possible lo identiiy and count individual B cells secreting antibod aaainst a
`specific antigen. In th
`irnples l form of th is assa 1 lymphocytes (commonly
`from U1 spleen) ar•o taken from animals that have been immunized against
`sheep red blood cells (S.ABCJ. They are then embedded in agar tog -ther· with
`an excess of SRBC so that the dish contains a "lawn" of immobilized SRBC
`with occasional lymphocytes in it. Under these conditions, the cells are unable
`to move, but any anti-SRBC antibody secreted by a B cell will diffuse outward
`and coat all SRBC in the vicinity of the secreting cell. Once the SRBCs are
`coated wilh antibody, they can be killed by adding complement (see p . 988).
`In this way, the pr-esence of each antibody-secreting cell is indicated by the
`presenc of a: cl -•ar spot, or plaque, in the opaque la er of SBBC. Th same
`assay can be used to count cells making antibody to other antigens, such as
`proteins or polysaccharides, simply by coupling these antigens to the surface
`of tbe SRBC.
`The s cond important advance was t·he demonstration that B 1 mpho(cid:173)
`cytes can b
`indue d to mak antibody by xposing th em to antigen in culture,
`where the cell inter·a tions an be manipulated and the environment con(cid:173)
`trolled . This led to the discover 1 that both T lymphocytes and sp •cializ.ed
`anl'igen-presenting cells are required for antibody production by B lympho(cid:173)
`cytes against most antigens; the cell interactions involved will be described in
`a later section of this chapter.
`
`Antibodies Have Two Identical Antigen-binding Sites11
`
`The simplest antibody molecules are Y-shaped molecules with two identical
`antigen-binding sites-one at the tip of each arm of the Y (Figure 17-15).
`Because of their two antigen-binding sites, they are said to be bivalent. Such
`antibody molecules can cross-link antigen molecules into a large lattice, as
`long as the antigen molecules ach have three or· more antigenic determinants
`
`I•'igm·1: 17-15 A highly schematic
`diagram of an antibody molecule with
`two identical antigen-binding sites.
`
`Genzyme Ex. 1010, pg 261
`
`

`
`The Functional Properties of Antibodies 965
`
`(see Figure 17-30). Once it reaches a certain size, such a lattice precipitates
`out of solution. This tendency of large immune complexes to precipitate is
`useful for detecting the presence of antibodies and antigens, as we shall see
`later. The efficiency of antigen-binding and cross-linking reactions by anti(cid:173)
`bodies is greatly increased by a flexible hinge region where the arms of the Y
`join the tail, allowing the distance between the two antigen-binding sites to
`vary (Figure 17-16).
`The protective effect of antibodies is not due simply to their ability to
`bind antigen. They engage in a variety of biological activities that are mediated
`by the tail of the Y. This part of the molecule determines what will happen
`to the antigen once it is bound. Antibodies with the same antigen-binding
`sites can have a variety of different tail regions and, therefore, different func(cid:173)
`tional properties.
`
`An Antibody Molecule Is Composed of Four Polypeptide
`Chains-Two Identical Light Chains and Two Identical
`Heavy Chains 14
`
`The basic structural unit of an antibody molecule consists of four polypeptide
`chains, two identical light (L) chains (each containing about 220 amino acids),
`and two identical heavy (H) chains (each usually containing about 440 amino
`acids). The four chains are held together by a combination of noncovalent
`interactions and covalent bonds (disulfide linkages). The molecule is com(cid:173)
`posed of two identical halves in which both Land H chains contribute almost
`equally to the two identical antigen-binding sites (Figure 17-17).
`The proteolytic enzymes papain and pepsin split antibody molecules
`into different characteristic fragments: papain produces two separate and
`identical Fab (fragment antigen binding) fragments, each with one antigen(cid:173)
`binding site, and one Fe fragment (so called because it readily crystallizes) .
`Pepsin, on the other hand, produces one F(ab' )2 fragment, so called because
`it consists of two covalently linked F(ab') fragments (each slightly large1' than
`a Fab fragment); the rest of the molecule is broken down into smaller frag(cid:173)
`ments (Figure 17-18). Because F(ab') 2 fragments are bivalent, they can still
`cross-link antigens and form precipitates, unlike the univalent Fab fragments.
`
`antigen(cid:173)
`binding site
`
`antigen(cid:173)
`binding site
`
`I hinge region of
`
`antibody molecule
`
`Figm·e 17-Hi The hinge region of
`an antibody molecule improves the
`efficiency of antigen binding and
`cross-linking.
`
`Figm·e 17- J 7 Schematic drawing of
`a typical antibody molecule
`composed of two identical heavy (H)
`chains and two identical light ILl
`chains. Note that the antigen-binding
`sites are formed by a complex of the
`amino-terminal regions of both L and
`H chains, but the tail region is formed
`by H chains alone. Each H chain
`contains one or more oligosaccharide
`chains of unknown function.
`
`COOH COOH
`
`Genzyme Ex. 1010, pg 262
`
`

`
`966 The Immune System
`
`PAPAIN CLEAVAGE
`
`PEPSIN CLEAVAGE
`
`Figure 17-18 The different
`fragments produced when antibody
`molecules are cleaved with two
`different proteolytic enzymes (papain
`and pepsin) provided important clues
`for the investigators who determined
`the four-chain structure of antibodies .
`
`1
`
`antigen-binding
`sites
`
`- 5-(cid:173)
`s-
`
`+
`
`1
`
`antigen-binding
`sites
`
`2 Fab fragments
`
`1 Fe
`fragment
`
`1 F(ab') 2 fragment
`
`v
`
`7 heavy chains
`
`0 0
`0 0 oo
`
`+ 0 0
`0
`0
`~0
`
`subfragments
`of Fe
`
`Neither of these fragments has the other biological properties of intact anti(cid:173)
`body molecules because they lack the tail (Fe) region that mediates these
`properties.
`
`v
`
`o: heavy chains
`
`There Are Five Different Classes of H Chains, Each with
`Different Biological Properties 11
`15
`'
`In higher vertebrates, there are five different classes of antibodies, IgA, IgD,
`IgE, IgG, and IgM, each with its own class of H chain-a, 8, E, "{, and fL,
`respectively; IgA molecules have a-chains, IgG molecules have "{-chains, and
`so on (Table 17-1). In addition, there are a number of subclasses of IgG and
`of some of the other immunoglobulins. The different H chains impart a dis(cid:173)
`tinctive conformation to the tail regions of antibodies and give each class
`characteristic properties of its own (Figure 17-19).
`IgG antibodies constitute the major class of immunoglobulin in the blood.
`They are copiously produced during secondary immune responses. The Fe
`region of IgG molecules binds to specific receptors on phagocytic cells, such
`as macrophages and polymorphonuclear leucocytes, thereby increasing the
`efficiency with which the phagocytic cells can ingest and destroy infecting
`microorganisms that have become coated with IgG antibodies produced in
`response to the infection (Figure 17-20). This is only one way in which IgG
`molecules combat infection. As well as binding to phagocytic cells, the Fe
`region of IgG can bind to and thereby activate the first component of the
`complement system, which under these circumstances unleashes a biochem(cid:173)
`ical attack that kills the microorganism (seep. 988).
`
`·v
`
`11 heavy chains
`
`li heavy chains
`
`Figure 17-19 Highly schematic diagram showing how each
`different class of antibody has a distinctive class of H chain
`that imparts a distinctive conformation to its tail, or Fe
`region.
`
`E heavy chains
`
`Genzyme Ex. 1010, pg 263

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket